ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals Inc (QB) (ELTP)

0.554125
-0.00416
( -0.75% )
Updated: 08:34:25

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.554125
Bid
0.5515
Ask
0.555
Volume
141,677
0.55 Day's Range 0.5595
0.1213 52 Week Range 0.7598
Market Cap
Previous Close
0.558285
Open
0.55
Last Trade
200
@
0.554125
Last Trade Time
08:34:25
Financial Volume
US$ 78,650
VWAP
0.555135
Average Volume (3m)
2,989,930
Shares Outstanding
1,068,273,108
Dividend Yield
-
PE Ratio
29.79
Earnings Per Share (EPS)
0.02
Revenue
56.63M
Net Profit
20.11M

About Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma... Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Carson City, Nevada, USA
Founded
-
Elite Pharmaceuticals Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker ELTP. The last closing price for Elite Pharmaceuticals (QB) was US$0.56. Over the last year, Elite Pharmaceuticals (QB) shares have traded in a share price range of US$ 0.1213 to US$ 0.7598.

Elite Pharmaceuticals (QB) currently has 1,068,273,108 shares outstanding. The market capitalization of Elite Pharmaceuticals (QB) is US$596.40 million. Elite Pharmaceuticals (QB) has a price to earnings ratio (PE ratio) of 29.79.

ELTP Latest News

ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition

ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition     Miami, FL – October 23, 2024 -- InvestorsHub NewsWire – EmergingGrowth.com, a leading...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0091251.674311926610.5450.570.5111825650.55576178CS
4-0.066075-10.6538213480.62020.6450.45514352500.55196101CS
120.14412535.15243902440.410.75980.391729899300.55093927CS
260.367525196.9587352630.18660.75980.162623388130.44795476CS
520.414125295.8035714290.140.75980.121316696230.36556734CS
1560.52162516050.03250.75980.02689741530.239216CS
2600.459125483.2894736840.0950.75980.0239802920.16783848CS

ELTP - Frequently Asked Questions (FAQ)

What is the current Elite Pharmaceuticals (QB) share price?
The current share price of Elite Pharmaceuticals (QB) is US$ 0.554125
How many Elite Pharmaceuticals (QB) shares are in issue?
Elite Pharmaceuticals (QB) has 1,068,273,108 shares in issue
What is the market cap of Elite Pharmaceuticals (QB)?
The market capitalisation of Elite Pharmaceuticals (QB) is USD 596.4M
What is the 1 year trading range for Elite Pharmaceuticals (QB) share price?
Elite Pharmaceuticals (QB) has traded in the range of US$ 0.1213 to US$ 0.7598 during the past year
What is the PE ratio of Elite Pharmaceuticals (QB)?
The price to earnings ratio of Elite Pharmaceuticals (QB) is 29.79
What is the cash to sales ratio of Elite Pharmaceuticals (QB)?
The cash to sales ratio of Elite Pharmaceuticals (QB) is 10.57
What is the reporting currency for Elite Pharmaceuticals (QB)?
Elite Pharmaceuticals (QB) reports financial results in USD
What is the latest annual turnover for Elite Pharmaceuticals (QB)?
The latest annual turnover of Elite Pharmaceuticals (QB) is USD 56.63M
What is the latest annual profit for Elite Pharmaceuticals (QB)?
The latest annual profit of Elite Pharmaceuticals (QB) is USD 20.11M
What is the registered address of Elite Pharmaceuticals (QB)?
The registered address for Elite Pharmaceuticals (QB) is 321 W. WINNIE LANE, #104, CARSON CITY, NEVADA, 89703
What is the Elite Pharmaceuticals (QB) website address?
The website address for Elite Pharmaceuticals (QB) is www.elitepharma.com
Which industry sector does Elite Pharmaceuticals (QB) operate in?
Elite Pharmaceuticals (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AABVFAberdeen International Inc (PK)
US$ 0.02478
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0204
(0.00%)
75k
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.02478
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0204
(0.00%)
75k
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
GRLTGrillit Inc (PK)
US$ 0.0009
(0.00%)
1.67M
BDMMFBurgundy Diamond Mines Ltd (PK)
US$ 0.02
(0.00%)
1.58M
EHGRFStar Entertainment Group Ltd (PK)
US$ 0.1312
(0.00%)
1.58M
MMEXMMEX Resources Corporation (PK)
US$ 0.0002
(0.00%)
1M
KYNCKyn Capital Group Inc (PK)
US$ 0.0006
(0.00%)
938.91k

ELTP Discussion

View Posts
HGilS HGilS 23 minutes ago
If you are older than 59.5 years old and you did an IRA to ROTH conversion this year, you will have to pay taxes on the conversion by January 15th 2025. If you want to push that date to April 15th 2025, you need to make sure you have paid 110% of your taxes amount for 2023 - both Federal and State tax. That makes you "grandfathered" and you can pay the big amount by April 15 2025. It is also better to pay that big tax on Elite gains using non roth IRA funds as they will grow more in 2025 and 2026.
👍️0
HGilS HGilS 39 minutes ago
Hi Kayak, If they do not pull out their money, it is unrealized gains and they do not have to worry in case of a buyout.
👍️0
snupoled snupoled 46 minutes ago
Good morning Sharkey, doing a little catch-up research today , could u briefly tell me what happened to lannet? Were they selling Adderall? Thanks
👍️0
ubueltp ubueltp 1 hour ago
I have owned too many companies w weak and poor leaders. They were much more overpriced as they did nothing to enhance shareholder value. Musk and Naz may be overpayed, but in today’s world, they have enhanced my wealth as I believe in both of their leadership/vision skills. I’m elated I own both companies, mostly due to those 2 people.
👍️ 2 💯 2
sharkey1 sharkey1 1 hour ago
Dianne updated the product page. Good to see.
👍️ 2
jammy32 jammy32 1 hour ago
Just my opinion again

How does Nasrat not lend elite the money to buy out sungen. It wasn’t because he was worried about losing money on the loan. If that was the case , he would have never paid sungen. It was , again, my opinion, just greed. Elite could have so much more revenue and profit now instead of so much of going to MIKAH ( HAKIM). Just so so so wrong in my opinion. What really pisses me off is his arrogance when asked about it. Screw you people for questioning me and my desire to make even more money.

Also, when will there be an accounting of all the shares he has and what were they for. How much did elite sell on the stuff that he sold elite ?

Last; question - do CEO’s of small companies make a million per year with a car and housing allowance. How did the board come up with this salary. Who did they benchmark against

All just my opinion.
😭 1 🤕 1
sharkey1 sharkey1 2 hours ago
Just for reference

https://www.findacode.com/ndc/labelers/Elite_Laboratories%2C_Inc.--64850
👍️ 1
JamesF1 JamesF1 4 hours ago
I hope prk8r3 answers. I’d like to know if AmeriSource Bergen Stocks Elite Vyvanse yet. Cardinal does not show it yet.
👍 1
NASDAQ2020 NASDAQ2020 4 hours ago
I’m beginning to wonder ?
Thx
👍️0
NASDAQ2020 NASDAQ2020 4 hours ago
Free PMs till the 1st.
👍️0
jour_trader jour_trader 11 hours ago
Able to see Vyvanse availability yet? Figured that might take a few weeks.
👍️ 1
kayak_wench kayak_wench 11 hours ago
Hi HGIS. I believe the poster was asking what would happen if they contributed to a Roth but later had income that meant they shouldn't have contributed to a Roth. There are income limits that if one is above prevents contribution to a Roth. One of those things that contribute to the income is capital gains. So sure if you contribute to a Roth when you were legally allowed to you don't pay tax on those gains. But again some posters are worried that a buyout that results in a cash payout in 2025 will push up the income unexpectedly very high.
👍️0
HGilS HGilS 11 hours ago
Hi kayak. If you do not pull out your gains from your Roth IRA you would not have to pay taxes. (After 59.5 years old). 5 year rule.
👍️0
kayak_wench kayak_wench 11 hours ago
Everything is a big word. It does means someone doesn't get the extra 10% penalty. But they would still have to pay short-term capital gain rates on the profits made in the investment, pull the money invested in 2025 and the money made in 2025 out of the Roth IRA before Apr 15 2026, and submit the necessary tax forms showing how the situation was corrected. But again, I think a buyout being finalized in 2026 is a long shot. But the stock price could jump up so high someone wants to sell. Bottom line is an additional $5k to $7k investment in a Roth worth the hassle?
👍️ 1
HGilS HGilS 13 hours ago
Are you older than 59.5? It changes everything.
👍️0
NASDAQ2020 NASDAQ2020 14 hours ago
Another possible option is do a traditional IRA for 2025 and don’t touch it till your retired and not earning any thing. Then you maybe able to take out $14,600 single $29,,200 married a year without any tax ?


Standard Deductions

For the tax year 2025, single taxpayers and married individuals filing separately will see their standard deduction - the amount of income that is not taxable - increase to $14,600 for 2024, up by $750 from 2023.

Married couples filing jointly will benefit from a standard deduction of $29,200, a $1,500 increase from 2024. Heads of households will have a standard deduction set at $22,500 for 2025, reflecting a $600 rise compared to the amount for tax year 2024.
👍️0
kennyt 335 kennyt 335 14 hours ago
I sure will thank you
👍️0
BuzzerF16 BuzzerF16 14 hours ago
If you earn to much to make a ROTH contribution you can still make a Traditional IRA contribution and immediately roll it over into your ROTH account. You just don't get the tax defferred benefit of the money for 2025. However, you still made a ROTH contribution that will now grow tax free. 
👍️0
kennyt 335 kennyt 335 15 hours ago
Thank you NASDAQ2020 l sent a private message but not sure it went through will try again on free Friday’s HAPPY NEW YEAR TO ALL🇺🇸
👍️0
NASDAQ2020 NASDAQ2020 15 hours ago
Kayak’s post also applies.
👍️0
NASDAQ2020 NASDAQ2020 15 hours ago
To best of my knowledge (which may not be right). If there is a buyout in 2025 I may not be eligible to do a Roth IRA 2025 because 1/3 of my ELTP is in a trading account. Let’s say I make a million dollars in that account that maybe too much to qualify to do a 2025/ Roth. I was going to do my 2025 Roth in Jan 2025. I decided to hold off , if no sale in 2025 I can do my Roth 2025 between Jan 2026 and April 2026.
What I need to know Kenny is if All your ELTP in a Roth now. If all is in Roth now you can probably do your 2025 Roth in Jan 2025 or anytime during the year. Let me know what % of your shares are in a Roth now and how much not in Roth.
You still can pm during Holiday if you don’t want to share with board.

Roth IRA income limits for 2025
The Roth IRA income limit to make a full contribution in 2025 is less than $150,000 for single filers, and less than $236,000 for those filing jointly. If you’re a single filer, you’re eligible to contribute a portion of the full amount if your MAGI is $150,000 or more, but less than $165,000. For those married filing jointly, the income range to contribute a portion of the full amount is $236,000 or more, but less than $246,000. If you’re a single filer and your MAGI is $165,000 or more, or if you’re a joint filer and your MAGI is $246,000 or more, you’re ineligible to contribute to a Roth IRA. Still, you can make contributions to a traditional IRA.

If you make lot of money out of Roth account during 2025 that may take you over the maximum you can make to qualify to do a Roth of $236,000 if filing jointly.
👍️0
kennyt 335 kennyt 335 17 hours ago
Thank you k w, you can tell lm a CPA hire candidate, but a firm believer in ELTP$$$$$ since 2011 and some Roth contributer, l still have some flexibility but love your very informative explanation thank you!!!
👍️0
kennyt 335 kennyt 335 17 hours ago
Thank you HG ELTP$$$$$$
👍️0
kayak_wench kayak_wench 17 hours ago
If your asking what happens to the money you contributed to the Roth in 2025, you will not pay taxes on gains in a roth.
If your asking what happens if you contribute to a Roth in 2025 because your income levels allow it when you contribute but at the end of 2025 they no longer are such you are allowed to contribute to a Roth (because you own Elite in non-roth IRA accounts that were forced to be liquidated in 2025 because of a buyout). So if you have a million shares of Elite not in a Roth right now and Elite gets bought out in 2025 then your income will be too high in 2025 to fund a Roth IRA. But what happens if you did fund an Roth IRA before you knew your income would be too high.

I want to first say that odds are Elite won't be bought out in 2025. News may hit that they are working on a buyout or one is being done, but it takes several months from the time a buyout is initiated to the date the stocks is liquidated. The date the buyout is announced is not relevant for your Roth contribution its the date your shares are converted to cash that matter.

If you fund a roth IRA but by the end of the year your income from capital gains means you shouldn't have funded your Roth IRA you will have to pull the Roth contribution back out of the Roth IRA before Apr 2026. If you do that you won't be fined on that contribution. But then there is the issue of money you made on the money in the Roth. As an example lets stay Elite gets sold and you invested $5k in a Roth that $5k increased to $15k ($10k profit). You will not be fined for the $10k if you pay the taxes you owe on it before April 2026. You will owe regular tax on it (probably 30%) because it will be treated as if it is not in a Roth IRA.

But there is an extra cost of $1,500 on that $15k if you are younger than 59 and half years of age. The $1,500 10% is for removing the $15k from the Roth IRA before you are old enough to do that. Sure your removing it because you have to, but that 10% still applies (I had to pull money out of a Roth once when I got extra income I didn't expect in the form of a bonus. My investment in the Roth actually lost money but I had to pay the extra 10% on the money I pulled out that was equal to the money I contributed). But despite the $1,500 fine you will still have overall made money of about $5,500 on your $5,000 roth investment if the stock triples from where it is now.

If your 59.5 or older you will not pay any 10% fine for pulling money out of a Roth, you will just have to pay taxes at the normal short-term tax rate. If that is 30% then you will make $7k off your $5k investment.

In addition you may have the added cost of paying someone to do your taxes in 2026 to make sure all the right forms are submitted. If you are tax savy and do your own returns already you can probably do this on your own. But given you asked this question, probably not. You will want to get your tax filing fixed in 2026 filing though, otherwise you get additional files each year they aren't fixed until you are caught (maybe never, maybe not). That fine looks to be 6%.

Again, I don't think we have a very high chance of a buyout being wrapped up in 2025. So if your willing to hire a CPA to make sure you properly pay taxes IF Elite is bought out in 2025 go for it.
👍 1
DrSleep DrSleep 18 hours ago
Loading the boat tomorrow
👍️ 1
HGilS HGilS 19 hours ago
No penalty if it is regular contribution and you take the money out after 65years old
👍️0
kennyt 335 kennyt 335 20 hours ago
Hi NASDAQ2020 what happens if l do contribute to Roth in 2025 and ELTP gets bought out , what penalties does it fall in TIA, hope your holidays have been a blast! ELTP $$$$$$$$$$
👍️0
NASDAQ2020 NASDAQ2020 20 hours ago
I’m adding Monday too.
GL
👍️ 1
Destiny Defined Destiny Defined 20 hours ago
Yawn......
👍️ 3 💯 1
Baylander1000 Baylander1000 20 hours ago
10% during a decade of cheap money. If I was getting a company car, housing along with all other expense covered at company expense I could live off Wifey's pay. I never been invited to a Company Christmas party. Corporations are becoming worst then GOV. They been taken back from the people since the 1990's living the fat life off the share holders. Its time Its time for nasrat to start sharing the wealth. Living off ELTP until I sell plan is old it benefits no one but the people running ELTP. Nasrat need to do something, Action not Talk, that benefits the share holders
👎️ 1
cdate cdate 24 hours ago
It’s about pride and a vision something you obviously lack. How many nights did you stay awake trying to make Elite successful ? Have your vision squashed and having to reorganize the companies future. Having to swallow your pride in deals with lenders, suppliers and other pharma companies that were not in elites favor due to leverage. Then finally turning the corner and being in the drivers seat and seeing that vision finally come to fruition. If I was Nas I would enjoy the next 12 months knowing he has this company positioned for success.
🎓️ 1 👍️ 12 😎 3
Maxthedog Maxthedog 1 day ago
One person keeps on crying about spilled milk, how much shares Nasrat has, his salary, 10% loans, and bah bah bah. But he never talks about the 5 drugs being launched, the amount of profits generic Vyvanse will bring in compared to Adderall (4x-6x), and it’s not shared. Talk about the company’s future and not the past. If you keep on bringing up the past, bring up your past, the profits you’ve made, less than a million dollars selling millions of shares at .15. Then, tell me how much you would’ve made compared to keeping the stock for another 6 months.
👍️ 4 💯 1
jammy32 jammy32 1 day ago
What I don’t get is what is Nasrat waiting for? He has over 300 m shares. He’s made a fortune off of his MIKAH , bull shit to elite, deal and he’s getting 10% interest on loans that he’s made. Oh and let’s not forget the million per year in salary and company car and house allowance. Why does he not just put his personal , what I consider greedy, interests aside, and just sell the company based on the future value. Why are we always waiting for what’s best for Nasrat ??????? Just my humble opinion
👎️ 3 🧟 2
aBeezlee aBeezlee 2 days ago
Oh I haven't sold. I started buying Elite around June, it's way too soon for me to think about leaving. But sometimes I trim positions to trade other stocks short term.
👍️0
aBeezlee aBeezlee 2 days ago
I haven't sold ELTP, and rarely close out positions. Unless the company is failing. Elite unlocked a key generic, so I feel their numbers in 2 quarters will show significant growth.
👍️ 9
Baylander1000 Baylander1000 2 days ago
I can appreciate all those who helped ELITE get to where it is today, but that help did not come without cost. At some point ELTP has to stand on its own two feet
👍️ 1
NASDAQ2020 NASDAQ2020 2 days ago
This press release has the market size for Concerta in 2020:

https://health.economictimes.indiatimes.com/news/pharma/dr-reddys-launches-generic-concerta-in-us-market/77906832

TheConcertabrand and generic market had U.S. sales of approximately USD $1.159 Billion
👍️ 3
NASDAQ2020 NASDAQ2020 2 days ago
Probably not our drug.
Our undisclosed CNS stimulant has overa Billion dollar market.
👍️ 2
luvwetscent luvwetscent 2 days ago
One particular basher with a big rack
👍️ 1
DrSleep DrSleep 2 days ago
Oh haha I was wondering how .30 was realistic 😂😂 went over my head!!
👍️0
 jangofett jangofett 2 days ago
He's just clowning the bashers 🐂🤑🤑🤑🤑🤑
👍️ 1
JamesF1 JamesF1 2 days ago
Thanks kayak_wench. Good information. I believe the patent for OROS drug delivery has expired. At least that is what a quick google search told me.
👍️ 2
kayak_wench kayak_wench 2 days ago
I asked ChatGPT and it reports that generic companies work around the need for a laser by replicating the OROS tech using traditional exteded-release methods. So it probably is Concerta....if this information wasn't a hallucination. It is interesting to learn more about why the drug is difficult to replicate. Given extended release tech is Elite's specialty they will eventually solve this problem, hope to hear about their success in the next few weeks!

Owning a laser is not strictly necessary to manufacture a generic Concerta. However, if a company seeks to replicate the exact OROS technology, they would need either access to the laser-drilling equipment or an agreement with the patent holder. Most manufacturers circumvent this by using alternative extended-release methods that meet regulatory bioequivalence requirements.

Currently, there are no generic versions of Concerta (methylphenidate extended-release) available that utilize the OROS (osmotic controlled-release oral delivery system) technology. The authorized generic, which did use OROS, was discontinued by Patriot Pharmaceuticals in January 2023.
AHP NETWORK

Other generic versions have employed alternative extended-release mechanisms, such as extended-release bead technology. However, these formulations have faced challenges in demonstrating bioequivalence to the brand-name Concerta. For instance, the FDA downgraded the therapeutic equivalence ratings of certain generics, indicating concerns about their efficacy compared to Concerta.
GOODRX

As a result, patients and healthcare providers have reported variability in therapeutic outcomes with these non-OROS generics. It's important for patients to consult with their healthcare providers to determine the most appropriate medication option for their needs.
👍️ 3
JamesF1 JamesF1 2 days ago
I found the 2017 market size (93 million). My guess is it’s larger now. https://investors.amneal.com/news/press-releases/press-release-details/2017/Impax-Announces-FDA-Approval-and-Launch-of-Additional-Strengths-of-Generic-Focalin-XR-Dexmethylphenidate-Hydrochloride-Extended-Release-Capsules-CII/default.aspx
👍️0
NASDAQ2020 NASDAQ2020 2 days ago
Do you know IMS market size of Focalin XR ?
👍️0
NASDAQ2020 NASDAQ2020 2 days ago
I don't remember Nasrat putting a name on it.
I believe Weizel may have came up with it based on IMS # s
👍️ 1
JamesF1 JamesF1 2 days ago
Thanks Jour, maybe Focalin XR is the drug if it’s not Concerta. Whatever it is, it would be a positive if a successful study is announced.
👍️ 1
jour_trader jour_trader 2 days ago
He has never mentioned it by name, but it's another large CNS drug, which has been interpreted as being Concerta.
👍️ 2
NASDAQ2020 NASDAQ2020 2 days ago
Im getting now just in case it dont go down, GLTY
👍️0
NASDAQ2020 NASDAQ2020 2 days ago
You should have listened at 2 cents. 1700% roi
another 1700% coming at buyout.
Still not too late .

Youve been wrong since 2 cents
👍️ 2